Search Results - "Ramanathapuram, Lalitha V"
-
1
Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw
Published in International journal of oral science (01-12-2014)“…Bacterial biofilms have emerged as potential critical triggers in the pathogenesis of bisphosphonate(BP)-related osteonecrosis of the jaw(ONJ) or BRONJ. BRONJ…”
Get full text
Journal Article -
2
Transforming growth factor β inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines
Published in Cancer research (Chicago, Ill.) (15-04-2003)“…Dendritic cell (DC)-based vaccines have exhibited minimal effectiveness in treating established tumors, likely because of factors present in the tumor…”
Get full text
Journal Article -
3
Dendritic Cells (DC) Facilitate Detachment of Squamous Carcinoma Cells (SCC), While SCC Promote an Immature CD16+ DC Phenotype and Control DC Migration
Published in Cancer microenvironment (01-04-2013)“…In the inflammatory mucosal microenvironment of head and neck SCC (HNSCC), DC express CD16 and are usually in direct contact with tumor cells. Mucosal and…”
Get full text
Journal Article -
4
Chemo-immunotherapy of breast cancer using vesiculated α-tocopheryl succinate in combination with dendritic cell vaccination
Published in Nutrition and cancer (01-01-2005)“…In this study, we evaluated the efficacy of vesiculated alpha-tocopheryl succinate (Valpha-TOS) in combination with non-antigen pulsed, nonmatured dendritic…”
Get full text
Journal Article -
5
Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines
Published in Cancer Immunology, Immunotherapy (01-02-2006)“…Alpha tocopheryl succinate (alpha-TOS) is a non-toxic vitamin E analog under study for its anti-cancer properties. In an earlier study, we showed that…”
Get full text
Journal Article -
6
α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells
Published in Cancer Immunology, Immunotherapy (01-07-2004)“…Dendritic cells (DCs) are considered potential candidates for cancer immunotherapy due to their ability to process and present antigens to T cells and…”
Get full text
Journal Article -
7
a-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells
Published in Cancer Immunology, Immunotherapy (01-07-2004)“…Purpose: Dendritic cells (DCs) are considered potential candidates for cancer immunotherapy due to their ability to process and present antigens to T cells and…”
Get full text
Journal Article -
8
Dendritic Cells (DC) Facilitate Detachment of Squamous Carcinoma Cells (SCC), While SCC Promote an Immature CD16^sup +^ DC Phenotype and Control DC Migration
Published in Cancer microenvironment (01-04-2013)“…In the inflammatory mucosal microenvironment of head and neck SCC (HNSCC), DC express CD16 and are usually in direct contact with tumor cells. Mucosal and…”
Get full text
Journal Article